The Diagnostic and Prognostic Value of Two Quantitative Clinical Tests in Patients With Lumbar Disc Herniation
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03832036 |
|
Recruitment Status :
Recruiting
First Posted : February 6, 2019
Last Update Posted : October 22, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
This study will investigate whether two clinical tests can be used to diagnose and predict the outcome in patients with lumbar disc herniation undergoing surgery and non-surgery treatment.
The two quantitative clinical tests include: electromyographic measurements using Paraspinal Mapping and pain responses using Quantitative Sensory Pain Testing.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Pain Lumbar Disc Herniation Back Pain Spinal Diseases Surgery | Diagnostic Test: Paraspinal Mapping and Quantitative Sensory Pain Test | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 150 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Diagnostic |
| Official Title: | The Diagnostic and Prognostic Value of Two Quantitative Clinical Tests in Patients |
| Actual Study Start Date : | October 1, 2018 |
| Estimated Primary Completion Date : | January 2021 |
| Estimated Study Completion Date : | January 2021 |
| Arm | Intervention/treatment |
|---|---|
| Experimental: Patients with lumbar disc herniation |
Diagnostic Test: Paraspinal Mapping and Quantitative Sensory Pain Test
Participants will be tested at baseline. |
- The diagnostic value of Paraspinal Mapping and Quantitative Sensory Pain Testing [ Time Frame: 8 week follow-up ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Clinical and radiologically diagnosed lumbar disc herniation.
- Low back pain with pain below the knee or anterior thigh pain in one or both legs.
- Dermatomal leg pain.
- Average pain intensity of 3 or more on a Numerical Rating Scale (0-10 NRS).
Exclusion Criteria:
- History of previous lumbar spine surgery.
- Surgery in general in the past 4 months.
- Current use of anticoagulants.
- Diagnoses which could confound with the diagnosis e.g. lumbar spinal stenosis, local muscle trauma, cancer metastases, fibromyalgia, neuropathy.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03832036
| Contact: Johanne B Filtenborg, M.Sc. | +4538164167 | johanne.brinch.larsen@rsyd.dk |
| Denmark | |
| Center for Rheumatology and Spine Diseases, Frederiksberg Hospital. | Recruiting |
| Frederiksberg, Denmark, 2000 | |
| Contact: Johanne B Filtenborg, M.Sc. | |
| Principal Investigator: | Johanne B Filtenborg, M.Sc. | Spine Centre Southern Denmark | |
| Study Director: | Berit Schiøttz-Christensen, MD | Spine Centre Southern Denmark | |
| Study Chair: | Søren O'Neill, DC | Spine Centre Southern Denmark | |
| Study Chair: | Kirstine Amris, MD | The Parker Institute, Frederiksberg Hospital | |
| Study Chair: | Gilles Fournier, MD, DC | Center for Rheumatology and Spine Diseases, Frederiksberg Hospital | |
| Study Chair: | Andrew J Haig, MD | University of Michigan |
| Responsible Party: | Spine Centre of Southern Denmark |
| ClinicalTrials.gov Identifier: | NCT03832036 |
| Other Study ID Numbers: |
201170138 |
| First Posted: | February 6, 2019 Key Record Dates |
| Last Update Posted: | October 22, 2020 |
| Last Verified: | October 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Electromyography Paraspinal Mapping Quantitative clinical tests Conditioned pain modulation |
Temporal pain summation Pain threshold Pain tolerance |
|
Spinal Diseases Hernia Pathological Conditions, Anatomical Bone Diseases Musculoskeletal Diseases |

